Shizouka Cancer Center

Phase	Trial [asc]	Trial Status	Site Status	Drug	NCT#
2	Efficacy and Safety of AMN107 in Patients With GastroIntestinal Stromal Tumors (GIST) Who Have Failed Both Imatinib and Sunitinib	Completed	Closed	Nilotinib	NCT00718562
3	Phase III, Open-Label Study of Nilotinib Versus Imatinib in GIST Patients (ENESTg1)	Completed	Closed	Nilotinib or Imatinib	NCT00785785